John Crumpler G1 Therapeutics, Inc

As of June 1, 2018


John Crumpler Net Worth

  • Net worth is estimated to be at least $98.05M
  • Owns at least 3,237,711 units of G1 Therapeutics, Inc stock
  • Sold an estimated value of $40.32M in the last year at G1 Therapeutics, Inc

John Crumpler Trading

  • Largest purchase of shares was 4,173,729 units , worth over $2M on May 24, 2017
  • Largest sale of shares was 800,000 units , worth over $38.4M on June 1, 2018
  • In total has made about 4 transactions over a year
  • Usually trades in May, with the busiest year in 2018 and 2017

Clay Thorp, Hatteras Venture Advisors IV SBIC LLC, Hatteras Venture Partners IV SBIC LP, ALEXANDER ROBERT INGRAM, John Crumpler, KENNETH LEE JR, MD Douglas Reed

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

John Crumpler Mailing Address

  • Mailing address is 280 S. Mangum Street Suite 350 Durham NC 27701 NC

G1 Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John E. Bailey, Jr. 2020 - $542,109 - $215,948 $758,057
Mark A. Velleca, M.D., Ph.D. 2020 $608,308 $3,069,704 $305,000 $8,550 $3,991,562
Mark A. Velleca, M.D., Ph.D. 2019 $589,700 $3,105,237 $280,108 $8,400 $3,983,445
Mark A. Velleca, M.D., Ph.D. 2018 $515,000 $1,044,529 $321,875 $33,250 $1,914,654
Jennifer K. Moses 2020 $398,583 $1,116,239 $141,050 $8,550 $1,664,422
Jennifer K. Moses 2019 $315,598 $972,601 $117,600 $8,400 $1,414,199
Mark Avagliano 2020 $431,417 $837,165 $151,200 $18,445 $1,438,227
Mark Avagliano 2019 $181,913 $5,100,560 $142,800 $53,117 $5,478,390
Rajesh K. Malik, M.D. 2020 $424,000 $836,733 $148,750 $8,550 $1,418,033
Rajesh K. Malik, M.D. 2019 $413,000 $828,195 $138,768 $8,400 $1,388,363
Rajesh K. Malik, M.D. 2018 $400,000 $696,968 $169,400 $8,250 $1,274,618
Soma Gupta 2020 $320,360 $2,212,758 $114,662 $100,000 $2,747,780
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1560241/000119312521136977/d122680ddef14a.htm

G1 Therapeutics, Inc Insider Trading

  • The most recent transaction was 30,000 units sold on July 15, 2021 by Mark Velleca worth over $570.26K
  • In the last 4 years, insiders at G1 Therapeutics, Inc sold an estimated value of $67.24M and bought an estimated value of $25.69M
  • The most active traders are Rajesh Malik, Chief Medical Officer,  Mark Velleca,  and Jennifer Moses, CFO
  • Insider trading is most common in June, with the busiest year in 2018

G1 Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1